[Studies on the objectivization of fenistil effectiveness]. 1977

M Dènes, and E Temesvári, and G Soòs

UI MeSH Term Description Entries
D001920 Bradykinin A nonapeptide messenger that is enzymatically produced from KALLIDIN in the blood where it is a potent but short-lived agent of arteriolar dilation and increased capillary permeability. Bradykinin is also released from MAST CELLS during asthma attacks, from gut walls as a gastrointestinal vasodilator, from damaged tissues as a pain signal, and may be a neurotransmitter. Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg,Bradykinin Acetate, (9-D-Arg)-Isomer,Bradykinin Diacetate,Bradykinin Hydrochloride,Bradykinin Triacetate,Bradykinin, (1-D-Arg)-Isomer,Bradykinin, (2-D-Pro)-Isomer,Bradykinin, (2-D-Pro-3-D-Pro-7-D-Pro)-Isomer,Bradykinin, (2-D-Pro-7-D-Pro)-Isomer,Bradykinin, (3-D-Pro)-Isomer,Bradykinin, (3-D-Pro-7-D-Pro)-Isomer,Bradykinin, (5-D-Phe)-Isomer,Bradykinin, (5-D-Phe-8-D-Phe)-Isomer,Bradykinin, (6-D-Ser)-Isomer,Bradykinin, (7-D-Pro)-Isomer,Bradykinin, (8-D-Phe)-Isomer,Bradykinin, (9-D-Arg)-Isomer,Arg Pro Pro Gly Phe Ser Pro Phe Arg
D003879 Dermatologic Agents Drugs used to treat or prevent skin disorders or for the routine care of skin. Agent, Dermatologic,Agent, Dermatological,Agents, Dermatologic,Dermatologic Agent,Dermatological Agents,Agents, Dermatological,Dermatological Agent
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006633 Histamine Antagonists Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only. Antihistamine,Antihistamines,Histamine Antagonist,Antagonist, Histamine,Antagonists, Histamine
D000982 Antipruritics Agents, usually topical, that relieve itching (pruritus). Antipruritic,Antipruritic Agent,Antipruritic Drug,Antipruritic Agents,Antipruritic Drugs,Agent, Antipruritic,Agents, Antipruritic,Drug, Antipruritic,Drugs, Antipruritic
D014581 Urticaria A vascular reaction of the skin characterized by erythema and wheal formation due to localized increase of vascular permeability. The causative mechanism may be allergy, infection, or stress. Hives,Urticarial Wheals,Urticarial Wheal,Urticarias,Wheal, Urticarial,Wheals, Urticarial

Related Publications

M Dènes, and E Temesvári, and G Soòs
March 1978, Zeitschrift fur die gesamte Hygiene und ihre Grenzgebiete,
M Dènes, and E Temesvári, and G Soòs
November 1965, Zeitschrift fur Alternsforschung,
M Dènes, and E Temesvári, and G Soòs
October 1975, Strahlentherapie,
M Dènes, and E Temesvári, and G Soòs
December 1965, Medizinische Klinik,
M Dènes, and E Temesvári, and G Soòs
March 1952, Zeitschrift fur Laryngologie, Rhinologie, Otologie und ihre Grenzgebiete,
M Dènes, and E Temesvári, and G Soòs
February 1978, Therapie der Gegenwart,
M Dènes, and E Temesvári, and G Soòs
March 1962, Praxis,
M Dènes, and E Temesvári, and G Soòs
January 1984, Biopharmaceutics & drug disposition,
M Dènes, and E Temesvári, and G Soòs
November 1961, Revue medicale de la Suisse romande,
M Dènes, and E Temesvári, and G Soòs
December 1965, Hippokrates,
Copied contents to your clipboard!